Crispr Therapeutics shares tumble after significant earnings miss
On May 21, 2025, Emerald Holding, Inc. (market cap: $886.91M), a company currently rated "GOOD" by InvestingPro’s Financial Health Score, conducted its Annual Meeting of Stockholders, where a quorum was present. Shareholders voted to re-elect Konstantin (Kosty) Gilis, Todd Hyatt, and Lisa Klinger as Class II directors to serve until the 2028 Annual Meeting or until their successors are elected. Additionally, the appointment of PricewaterhouseCoopers LLP as the company’s independent auditor for the year ending December 31, 2025, was ratified. The company, which maintains a healthy current ratio of 1.59 and achieved 4.87% revenue growth in the last twelve months, is scheduled to report its next earnings on August 11, 2025.
The company reported that approximately 196,124,330 shares were represented at the meeting, out of a total of 199,597,204 shares outstanding as of the record date, March 31, 2025. The detailed results of the voting were as follows:
For the re-election of directors, Kosty Gilis received 187,243,934 votes for and 5,019,751 withheld, with 3,860,645 broker non-votes. Todd Hyatt received 192,199,870 votes for and 63,815 withheld, with 3,860,645 broker non-votes. Lisa Klinger received 192,209,262 votes for and 54,423 withheld, with 3,860,645 broker non-votes.
For the ratification of PricewaterhouseCoopers LLP as the company’s independent auditor, there were 195,888,821 votes for, 225,375 against, and 10,134 abstained.
This information is based on a press release statement from Emerald Holding, Inc. For comprehensive analysis and additional insights, including 10 key ProTips and detailed financial metrics, visit InvestingPro’s detailed research report on EEX.
In other recent news, Emerald Expositions Events Inc (NYSE:EEX) reported its financial results for the first quarter of 2025, revealing a mixed performance. The company achieved a revenue of $147.7 million, surpassing the forecast of $143.8 million, but its earnings per share (EPS) fell short at $0.08 compared to the expected $0.11. The revenue growth was primarily driven by the connections business and effective cost management strategies. Additionally, Emerald Expositions’ adjusted EBITDA increased by 34.7% to $53.6 million, with a margin expansion to 36.3%. The company continues to focus on growth through strategic acquisitions, with recent regulatory approval to acquire This Is Beyond, a collection of high-end experiential events. Furthermore, Emerald Expositions is integrating InsurTech Insights, which contributed approximately $5 million to the quarter’s revenue. Looking ahead, the company has maintained its full-year 2025 revenue guidance of $450 million to $460 million, with adjusted EBITDA expected to range from $120 million to $125 million.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.